Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1988-10-3
|
pubmed:abstractText |
The authors have studied the natural history of 377 patients with Stage I cutaneous malignant melanoma followed at the Arizona Cancer Center, Tucson. Two hundred eight patients, or 55%, remained free of metastatic disease after a median follow-up of 30 months. The survival at 5, 8, and 10 years was 69, 65, and 63%, respectively. Natural breakpoints in Breslow thickness for survival occurred at 0.85, 1.95, and 4.00 mm. These are not significantly different from those found by other investigators. A step-down multivariate analysis using the Cox regression model yielded four factors as highly significant in predicting survival: Breslow thickness (P less than 0.001), an age/sex interaction (P = 0.0012), clinical ulceration (P = 0.0039), and a prophylactic node dissection (P = 0.019). No predictive value for a BANS or non-BANS location was detected. These results are discussed in reference to other large series which describe the natural history of cutaneous melanoma.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0008-543X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1207-14
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3409189-Arizona,
pubmed-meshheading:3409189-Female,
pubmed-meshheading:3409189-Follow-Up Studies,
pubmed-meshheading:3409189-Humans,
pubmed-meshheading:3409189-Male,
pubmed-meshheading:3409189-Melanoma,
pubmed-meshheading:3409189-Middle Aged,
pubmed-meshheading:3409189-Neoplasm Staging,
pubmed-meshheading:3409189-Risk Factors,
pubmed-meshheading:3409189-Skin Neoplasms
|
pubmed:year |
1988
|
pubmed:articleTitle |
Cutaneous malignant melanoma (Arizona Cancer Center experience). I. Natural history and prognostic factors influencing survival in patients with stage I disease.
|
pubmed:affiliation |
Department of Internal Medicine, Arizona Cancer Center, Tucson.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|